Narrow Gauge Ventures
Venture capitalAnn Arbor · Seed–Series B · 1 people tracked
Also known as Narrow Gauge Ventures Syndicate
Investment thesis
Narrow Gauge Ventures believes the inefficiencies of the U.S. healthcare system require a full replacement of infrastructure rather than incremental change. With digital foundations such as electronic medical records, genomics, and telemedicine now in place, the firm sees an opportunity for transformative innovation. As early- and middle-stage investors with backgrounds as both investors and entrepreneurs in the first wave of digital health, they target companies with strong teams, proven revenue in growing markets, a focus on sustainable growth, and capital efficiency, and aim to be active investors supporting their portfolio's growth.
Source: firm website, verified Aug 7, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 2 of 6 portfolio companiesDigital Health ×2Healthtech ×2Enterprise Software ×1SaaS ×1
HQs:United States×1
Investments · 6 tracked
founders shown can be your intro path
CareInsights (formerly Agathos) is a mobile-first platform that delivers personalized peer-comparison insights on clinical metrics directly to physicians via text to drive improvements in care quality and reduce costs.
Digital HealthEnterprise SoftwareHealthtechBoulder, US
Andrew Trees(Executive Officer, Director)STEVE WAYE(Executive Officer, Director)
BoardMARK BAKKEN(Director)inELISE MILLER HOFFMAN(Director)in
Co-investorsBetter Ventures Central LlcNewfund CapitalCultivation CapitalHealthX VenturesI2BF Global Ventures
A data-driven platform designed to facilitate communication and collaboration across studies for participants, researchers, and trial leaders.
Ripple Science offers EnrollNow, a HIPAA-compliant, SOC 2-certified platform for managing research participant prescreening, enrollment, scheduling, and communication.
Digital HealthHealthtechSaaS
Co-investorsDundee Venture CapitalID VenturesInvest MichiganMercury FundMichigan Capital NetworkMichigan Rise+1 more
A team of product strategists, engineers, data scientists and designers building products and tools to advance life sciences and facilitate healthcare innovation.
Co-investorsM25Stout Street Capital
Portfolio news
latest coverage across their companiesAgathos · prnewswire.com · Jun 24, 2025
Frequently asked questions
- How many investments has Narrow Gauge Ventures made?
- Narrow Gauge Ventures has 6 tracked investments.
- What stage does Narrow Gauge Ventures invest at?
- Narrow Gauge Ventures invests at the Seed, Series A, Series B stages.
- What is Narrow Gauge Ventures's typical check size?
- Narrow Gauge Ventures typically writes checks of $100K – $500K.
- What sectors does Narrow Gauge Ventures focus on?
- Narrow Gauge Ventures focuses on Digital Health, Enterprise Software, Healthtech, SaaS.
- Where is Narrow Gauge Ventures located?
- Narrow Gauge Ventures is headquartered in Ann Arbor, US.
- Who does Narrow Gauge Ventures co-invest with?
- Narrow Gauge Ventures most often shares deals with Better Ventures Central Llc, M25, Mercury Fund, among 10 tracked co-investors.
Similar investors
8VC is a venture capital firm investing across logistics, life sciences, healthcare, IT infrastructure, and government/defense, guided by its Smart Enterprise thesis focused on data integration and platform network effects.
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Foundation Capital is an early-stage venture capital firm that commits to founders at the idea stage and maintains long-term relationships with portfolio companies through their growth journey.
GV (Google Ventures) is a venture capital firm that has invested in artificial intelligence and machine learning since its early days, building a global portfolio of more than 100 AI companies across infrastructure, life sciences, and applications.
Karma Ventures is a European venture capital firm investing in deep-tech software startups at late seed and Series A stages.